How Alpha Linolenic Acid May Sustain Blood–Brain Barrier Integrity and Boost Brain Resilience against Alzheimer’s Disease
Tóm tắt
Cognitive decline, the primary clinical phenotype of Alzheimer’s disease (AD), is currently attributed mainly to amyloid and tau protein deposits. However, a growing body of evidence is converging on brain lipids, and blood–brain barrier (BBB) dysfunction, as crucial players involved in AD development. The critical role of lipids metabolism in the brain and its vascular barrier, and its constant modifications particularly throughout AD development, warrants investigation of brain lipid metabolism as a high value therapeutic target. Yet, there is limited knowledge on the biochemical and structural roles of lipids in BBB functionality in AD. Within this framework, we hypothesize that the ApoE4 genotype, strongly linked to AD risk and progression, may be related to altered fatty acids composition in the BBB. Interestingly, alpha linolenic acid (ALA), the precursor of the majoritarian brain component docosahexaenoic acid (DHA), emerges as a potential novel brain savior, acting via BBB functional improvements, and this may be primarily relevant to ApoE4 carriers.
Từ khóa
Tài liệu tham khảo
Montagne, 2020, APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline, Nature, 581, 71, 10.1038/s41586-020-2247-3
Kadry, 2020, A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity, Fluids Barriers CNS, 17, 69, 10.1186/s12987-020-00230-3
Lacoste, 2014, Mfsd2a is critical for the formation and function of the blood-brain barrier, Nature, 509, 507, 10.1038/nature13324
Nguyen, 2014, Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid, Nature, 509, 503, 10.1038/nature13241
Andreone, 2017, Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis, Neuron, 94, 581, 10.1016/j.neuron.2017.03.043
Rand, 2021, Caspase-1: An important player and possible target for repair of the blood-brain barrier underlying neurodegeneration, Neural Regen. Res., 16, 2390, 10.4103/1673-5374.313031
Hung, 2022, Technology-based group exercise interventions for people living with dementia or mild cognitive impairment: A scoping review protocol, BMJ Open, 12, e055990, 10.1136/bmjopen-2021-055990
Cummings, 2022, Alzheimer’s disease drug development pipeline: 2022, Alzheimers Dement, 8, e12295
Lotan, 2021, Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial, J. Alzheimers Dis., 82, 1785, 10.3233/JAD-210131
Hollander, 2014, Dietary enrichment with alpha-linolenic acid during pregnancy attenuates insulin resistance in adult offspring in mice, Arch. Physiol. Biochem., 120, 99, 10.3109/13813455.2014.940352
Raz, 2015, Alpha linolenic acid in maternal diet halts the lipid disarray due to saturated fatty acids in the liver of mice offspring at weaning, Lipids Health Dis., 14, 14, 10.1186/s12944-015-0012-7
Goez, 2018, High-fat diet protects the blood-brain barrier in an Alzheimer’s disease mouse model, Aging Cell, 17, e12818, 10.1111/acel.12818
Gille, 2021, Recent Advances in Studying Age-Associated Lipids Alterations and Dietary Interventions in Mammals, Front. Aging, 2, 773795, 10.3389/fragi.2021.773795
Cutuli, 2017, Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging, Curr. Neuropharmacol., 15, 534, 10.2174/1570159X14666160614091311
Bowman, 2019, A blood-based nutritional risk index explains cognitive enhancement and decline in the multidomain Alzheimer prevention trial, Alzheimers Dement, 5, 953
Norwitz, N.G., Saif, N., Ariza, I.E., and Isaacson, R.S. (2021). Precision nutrition for alzheimer’s prevention in apoe4 carriers. Nutrients.
Yassine, 2022, Nutrition state of science and dementia prevention: Recommendations of the Nutrition for Dementia Prevention Working Group, Lancet Healthy Longev., 3, e501, 10.1016/S2666-7568(22)00120-9
Abbott, 2010, Structure and function of the blood-brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030
Epand, 2007, Membrane lipid polymorphism: Relationship to bilayer properties and protein function, Methods Mol. Biol., 400, 15, 10.1007/978-1-59745-519-0_2
Mukerjee, S., Saeedan, A.S., Ansari, M.N., and Singh, M. (2021). Polyunsaturated fatty acids mediated regulation of membrane biochemistry and tumor cell membrane integrity. Membranes, 11.
Dyall, 2015, Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Front, Aging Neurosci., 7, 52
Gimenez, 2011, Nutritional deficiencies and phospholipid metabolism, Int. J. Mol. Sci., 12, 2408, 10.3390/ijms12042408
2006, Membrane-lipid therapy: A new approach in molecular medicine, Trends Mol. Med., 12, 34, 10.1016/j.molmed.2005.11.004
Hollander, 2021, Dietary alpha linolenic acid in pregnant mice and during weaning increases brain docosahexaenoic acid and improves recognition memory in the offspring, J. Nutr. Biochem., 91, 108597, 10.1016/j.jnutbio.2021.108597
Montagne, 2017, Alzheimer’s disease: A matter of blood-brain barrier dysfunction?, J. Exp. Med., 214, 3151, 10.1084/jem.20171406
Chang, 2009, Essential fatty acids and human brain, Acta Neurol. Taiwan, 18, 231
Bazan, 2011, Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity, Mol. Neurobiol., 44, 216, 10.1007/s12035-011-8200-6
Svennerholm, 1997, Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes, Acta Neuropathol., 94, 345, 10.1007/s004010050717
Sampath, 2005, Polyunsaturated fatty acid regulation of genes of lipid metabolism, Annu. Rev. Nutr., 25, 317, 10.1146/annurev.nutr.25.051804.101917
Edlund, 1991, Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease, Lipids, 26, 421, 10.1007/BF02536067
Hennebelle, 2014, Ageing and apoE change DHA homeostasis: Relevance to age-related cognitive decline, Proc. Nutr. Soc., 73, 80, 10.1017/S0029665113003625
Kurz, 2022, Dysfunction of the blood-brain barrier in Alzheimer’s disease: Evidence from human studies, Neuropathol. Appl. Neurobiol., 48, e12782, 10.1111/nan.12782
Sweeney, 2018, Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders, Nat. Rev. Neurol., 14, 133, 10.1038/nrneurol.2017.188
Cullis, 1979, Lipid polymorphism and the functional roles of lipids in biological membranes, Biochim. Biophys. Acta, 559, 399, 10.1016/0304-4157(79)90012-1
Cai, 2018, Role of Blood-Brain Barrier in Alzheimer’s Disease, J. Alzheimers Dis., 63, 1223, 10.3233/JAD-180098
Barnes, 2021, Omega-3 fatty acids are associated with blood-brain barrier integrity in a healthy aging population, Brain Behav., 11, e2273, 10.1002/brb3.2273
Chang, 2013, Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats, J. Nutr. Biochem., 24, 2127, 10.1016/j.jnutbio.2013.08.004
Kuo, 2010, The combined effects on neuronal activation and blood-brain barrier permeability of time and n-3 polyunsaturated fatty acids in mice, as measured in vivo using MEMRI, Neuroimage, 50, 1384, 10.1016/j.neuroimage.2010.01.057
Hooijmans, 2012, The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer’s pathology in animal models of Alzheimer’s disease: A systematic review and meta-analysis, J. Alzheimers Dis., 28, 191, 10.3233/JAD-2011-111217
Yamazaki, 2019, Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression, Brain, 142, 1077, 10.1093/brain/awz011
Ntambi, 2001, Polyunsaturated fatty acid regulation of gene expression, J. Mol. Neurosci., 16, 273, 10.1385/JMN:16:2-3:273
Cho, 1999, Cloning, expression, and fatty acid regulation of the human delta-5 desaturase, J. Biol. Chem., 274, 37335, 10.1074/jbc.274.52.37335
McNamara, 2008, The aging human orbitofrontal cortex: Decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity, Prostaglandins Leukot Essent Fatty Acids, 78, 293, 10.1016/j.plefa.2008.04.001
Bazan, 2003, Synaptic lipid signaling: Significance of polyunsaturated fatty acids and platelet-activating factor, J. Lipid Res., 44, 2221, 10.1194/jlr.R300013-JLR200
Katsuki, 1995, Arachidonic acid as a neurotoxic and neurotrophic substance, Prog. Neurobiol., 46, 607, 10.1016/0301-0082(95)00016-O
Wood, 2021, Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A, Nature, 596, 444, 10.1038/s41586-021-03782-y
Leikin, 1995, Characterization of the lipid surrounding the delta 6-desaturase of rat liver microsomes, Biochim. Biophys. Acta, 1256, 13, 10.1016/0005-2760(94)00244-S
Dyall, 2008, Neurological benefits of omega-3 fatty acids, Neuromolecul. Med., 10, 219, 10.1007/s12017-008-8036-z
Von Schacky, C. (2021). Importance of EPA and DHA blood levels in brain structure and function. Nutrients.
Liu, 2020, Acute EPA-induced learning and memory impairment in mice is prevented by DHA, Nat. Commun., 11, 5465, 10.1038/s41467-020-19255-1
Bradbury, J. (2011). Docosahexaenoic acid (DHA): An ancient nutrient for the modern human brain. Nutrients, 3.
Du, 2012, Dairy fat blends high in α-linolenic acid are superior to n-3 fatty-acid-enriched palm oil blends for increasing DHA levels in the brains of young rats, J. Nutr. Biochem., 23, 1573, 10.1016/j.jnutbio.2011.10.011
Tu, 2010, Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression, Prostaglandins Leukot Essent Fatty Acids, 83, 61, 10.1016/j.plefa.2010.04.001
Majou, 2021, Synthesis of DHA (omega-3 fatty acid): FADS2 gene polymorphisms and regulation by PPARα, OCL, 28, 43, 10.1051/ocl/2021030
Tosi, 2014, Delta-5 and delta-6 desaturases: Crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease, Adv. Exp. Med. Biol., 824, 61, 10.1007/978-3-319-07320-0_7
Das, 2006, Essential fatty acids: Biochemistry, physiology and pathology, Biotechnol. J., 1, 420, 10.1002/biot.200600012
Akiyama, 2000, Inflammation and Alzheimer’s disease, Neurobiol. Aging, 21, 383, 10.1016/S0197-4580(00)00124-X
Lindenau, K.L., Barr, J.L., Higgins, C.R., Sporici, K.T., Brailoiu, E., and Brailoiu, G.C. (2022). Blood-Brain Barrier Disruption Mediated by FFA1 Receptor-Evidence Using Miniscope. Int. J. Mol. Sci., 23.
Heath, R.J., and Wood, T.R. (2021). Why have the benefits of DHA not been borne out in the treatment and prevention of alzheimer’s disease? A narrative review focused on DHA metabolism and adipose tissue. Int. J. Mol. Sci., 22.
Brenner, 1974, The oxidative desaturation of unsaturated fatty acids in animals, Mol. Cell. Biochem., 3, 41, 10.1007/BF01660076
Astarita, G., Jung, K.-M., Vasilevko, V., Dipatrizio, N.V., Martin, S.K., Cribbs, D.H., Head, E., Cotman, C.W., and Piomelli, D. (2011). Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer’s disease. PLoS ONE, 6.
Cohen, 2022, The effect of α-linolenic acid enrichment in perinatal diets in preventing high fat diet-induced SCD1 increased activity and lipid disarray in adult offspring of low density lipoprotein receptor knockout (LDLRKO) mice, Prostaglandins Leukot. Essent. Fatty Acids, 184, 102475, 10.1016/j.plefa.2022.102475
Bernoud, 1998, Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro, J. Lipid Res., 39, 1816, 10.1016/S0022-2275(20)32169-6
Taylor, 2022, Activated endothelial cells induce a distinct type of astrocytic reactivity, Commun. Biol., 5, 282, 10.1038/s42003-022-03237-8
Wang, 2022, trans-2-Enoyl-CoA Reductase Tecr-Driven Lipid Metabolism in Endothelial Cells Protects against Transcytosis to Maintain Blood-Brain Barrier Homeostasis, Research, 2022, 9839368
Martinat, M., Rossitto, M., Di Miceli, M., and Layé, S. (2021). Perinatal dietary polyunsaturated fatty acids in brain development, role in neurodevelopmental disorders. Nutrients, 13.
Phillips, M.A., Childs, C.E., Calder, P.C., and Rogers, P.J. (2015). No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer’s Disease: A Randomised Controlled Trial. Int. J. Mol. Sci., 16.
Quinn, 2010, Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial, JAMA, 304, 1903, 10.1001/jama.2010.1510
Burdge, 2005, Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults, Reprod. Nutr. Dev., 45, 581, 10.1051/rnd:2005047
Burdge, 2004, Alpha-linolenic acid metabolism in men and women: Nutritional and biological implications, Curr. Opin. Clin. Nutr. Metab. Care, 7, 137, 10.1097/00075197-200403000-00006
Hrelia, 1989, Age-related changes in linoleate and alpha-linolenate desaturation by rat liver microsomes, Biochem. Biophys. Res. Commun., 163, 348, 10.1016/0006-291X(89)92142-6
Meaney, 2004, Brain cholesterol: Long secret life behind a barrier, Arterioscler. Thromb. Vasc. Biol., 24, 806, 10.1161/01.ATV.0000120374.59826.1b
Riddell, 2008, Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels, J. Neurosci., 28, 11445, 10.1523/JNEUROSCI.1972-08.2008
Varma, 2021, Abnormal brain cholesterol homeostasis in Alzheimer’s disease-a targeted metabolomic and transcriptomic study, Npj Aging Mech. Dis., 7, 11, 10.1038/s41514-021-00064-9
Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat. Rev. Neurol., 9, 106, 10.1038/nrneurol.2012.263
Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443
Vandal, 2014, Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2, J. Neurochem., 129, 516, 10.1111/jnc.12640
Barisano, 2022, A “multi-omics” analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice, J. Exp. Med., 219, e20221137, 10.1084/jem.20221137
Saidi, 2007, Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels, J. Stroke Cerebrovasc. Dis., 16, 160, 10.1016/j.jstrokecerebrovasdis.2007.03.001
Miranda, 2022, Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice, Transl. Psychiatry, 12, 129, 10.1038/s41398-022-01881-6
Qi, 2021, ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism, Cell Rep., 34, 108572, 10.1016/j.celrep.2020.108572
Mallick, 2022, Modulation of endothelium function by fatty acids, Mol. Cell. Biochem., 477, 15, 10.1007/s11010-021-04260-9